Kunxian capsules in the treatment of patients with ankylosing spondylitis: a randomized placebo-controlled clinical trial

BACKGROUND: Ankylosing spondylitis (AS) is a chronic inflammatory autoimmune disease. Kunxian capsule, a Chinese patent medicine which has been used in the treatment of immunologic diseases for many years in China, has anti-inflammatory and immunoregulatory effects. This study investigates the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiuxia, Li, Li, Bi, Liqi, Xiao, Changhong, Lin, Zhiming, Cao, Shuangyan, Liao, Zetao, Gu, Jieruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957347/
https://www.ncbi.nlm.nih.gov/pubmed/27449221
http://dx.doi.org/10.1186/s13063-016-1438-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957347/
https://www.ncbi.nlm.nih.gov/pubmed/27449221
http://dx.doi.org/10.1186/s13063-016-1438-6

Ejemplares similares